发明申请
US20100305140A1 BENZIMIDAZOLE DERIVATIVES WHICH ARE TO BE USED AS ANTAGONIST FOR THE CB1-RECEPTOR
审中-公开
被用作CB1受体拮抗剂的苯并咪唑衍生物
- 专利标题： BENZIMIDAZOLE DERIVATIVES WHICH ARE TO BE USED AS ANTAGONIST FOR THE CB1-RECEPTOR
- 专利标题（中）： 被用作CB1受体拮抗剂的苯并咪唑衍生物
-
申请号： US12303643申请日： 2007-06-11
-
公开(公告)号： US20100305140A1公开(公告)日： 2010-12-02
- 发明人: William Brown , Daniel Page , Sanjay Srivastava , Christopher Walpole , Zhong-Yong Wei , Hua Yang
- 申请人： William Brown , Daniel Page , Sanjay Srivastava , Christopher Walpole , Zhong-Yong Wei , Hua Yang
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 国际申请： PCT/SE2007/000562 WO 20070611
- 主分类号： A61K31/496
- IPC分类号： A61K31/496 ; C07D403/10 ; C07D401/12 ; A61K31/4184 ; A61K31/454 ; A61P1/00
摘要：
Compounds of formula I or pharmaceutically acceptable salts thereof: wherein X, A, R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
信息查询
IPC分类:
